GREAT POINT PARTNERS LLC - DIPEXIUM PHARMACEUTICALS INC ownership

DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 13 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GREAT POINT PARTNERS LLC ownership history of DIPEXIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2016$2,594,000
+197.8%
178,930
+103.5%
0.66%
+165.9%
Q2 2016$871,000
-27.7%
87,914
-29.2%
0.25%
-53.5%
Q2 2014$1,204,000
-52.2%
124,125
-50.4%
0.54%
-59.3%
Q1 2014$2,520,000250,0001.32%
Other shareholders
DIPEXIUM PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Park West Asset Management LLC 194,340$253,0000.02%
MIDDLETON & CO INC/MA 15,848$21,0000.01%
Acrospire Investment Management LLC 4,220$5,0000.00%
Tower Research Capital LLC (TRC) 19,942$26,0000.00%
A.R.T. Advisors, LLC 32,426$42,0000.00%
FNY Partners Fund LP 500$5,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 43,447$56,0000.00%
Raymond James Financial Services Advisors, Inc. 13,200$17,0000.00%
GOLDMAN SACHS GROUP INC 24,378$32,0000.00%
MORGAN STANLEY 7,566$10,0000.00%
View complete list of DIPEXIUM PHARMACEUTICALS INC shareholders